loader
Please Wait
Applying Filters...
menu
    • menu

    Quality Alerts: Class 2 Medicines Recall: Various Marketing Authorisation Holders and parallel distributor companies, Irbesartan-containing products, EL (21)A/19 - Euroapi

    MenuEuroapi

    Uploaded: 2022
    News
    Market update EUROAPI Strengthens Shareholder Commitment

    16 Dec 2025

    // PRESS RELEASE

    Tristan Imbert Co-Opted As Independent Director

    10 Dec 2025

    // PRESS RELEASE

    EUROAPI Boosts Pharmaceutical Innovation With Med4Cure

    23 Oct 2025

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    EUROAPI VB

    Contact Supplier

    Website

    DCAT Week

    Hilton Midtown

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/a6j54hn1CIE
    Xls

    CATEGORY PAGE
    Menu

    Euroapi

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    SERVICES

    Key Services KEY SERVICES

    EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PC100795
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.